New research and developments, as well as studies with larger sample sizes that should adopt a prospective design and appropriate score for Her2 and Ki67 expression, may provide more information about these biomarkers for their use in early cancer detection and prognosis prediction. The gene discussed is MKI67; the disease is cancer.